Quote | Enfusion Inc. Class A (NYSE:ENFN)
Last: | $8.77 |
---|---|
Change Percent: | 0.23% |
Open: | $8.56 |
Close: | $8.77 |
High: | $8.805 |
Low: | $8.485 |
Volume: | 238,127 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Enfusion Inc. Class A (NYSE:ENFN)
2024-07-01 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 23:43:21 ET Summary Enfusion targets to grow its top line at a faster pace by optimizing its customer mix. Positive operating leverage and an increase in operating efficiency will support higher EBITDA margins for Enfusion. I expect ENFN to achieve revenue growth ac...
Message Board Posts | Enfusion Inc. Class A (NYSE:ENFN)
Subject | By | Source | When |
---|---|---|---|
Poor ENFN...and here's why... | acesharkster | investorshub | 07/29/2003 3:02:10 AM |
ENFN: The Slow Road to Wealth or Just | acesharkster | investorshub | 07/29/2003 2:35:08 AM |
:) ENFN: Definitely not an issue for "Sharks"! | slow_feet | investorshub | 07/25/2003 12:04:48 AM |
Adios ENFN... | acesharkster | investorshub | 07/24/2003 11:33:13 PM |
ace, Me thinks you've been following ENFN longer than | slow_feet | investorshub | 07/22/2003 5:04:33 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-11 07:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Executive Officer, Oleg Movchan, and Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will pa...